Progyny, Inc. held its fourth quarter 2025 earnings conference call on February 26, 2026. The call featured prepared remarks from company executives followed by a question-and-answer session. Forward-looking statements were highlighted regarding the company's financial outlook and market strategies.
Progyny, Inc. (PGNY), a provider of fertility benefits solutions, conducted its Q4 2025 earnings conference call on February 26, 2026, at 4:45 PM EST. The event was hosted by James Hart, Vice President of Investor Relations, who introduced CEO Peter Anevski and Chief Financial Officer Mark Livingston.
The call began with an operator's welcome and instructions for participants. Hart thanked the operator and welcomed attendees to the fourth quarter conference call. He noted that the session would start with prepared remarks before opening for questions.
Hart reminded participants that comments and responses would reflect management's views as of that date. These included forward-looking statements under federal securities laws, covering the financial outlook for the first quarter and full year 2026. The statements addressed assumptions and drivers such as the anticipated number of clients and covered lives for 2026, demand for Progyny's solutions, expected employment levels among clients and served industries, utilization rates and mix, potential benefits of the solution, ability to acquire new clients and retain or upsell existing ones, market opportunity, and business strategy, plans, goals, and expectations for market position, future operations, and other financial and operating information.
Conference call participants included analysts from firms such as Truist Securities, Jefferies LLC, Leerink Partners, KeyBanc Capital Markets, Barclays Bank, Cantor Fitzgerald, and Citizens JMP Securities.